Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   More Robert J
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   341,069    

Indirect Shares

   7,074,016      
Direct Value   $569,888    

Indirect Value

   $2,996,433      
Total Shares   7,415,085      
Total Value   $3,566,321      


Volcano Corp $0 Orexigen Therapeutics, Inc. $88 Glaukos Corp $569,800 Sienna Biopharmaceuticals, Inc. $0 Vir Biotechnology, Inc. $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $88 Glaukos Corp $569,800 Sienna Biopharmaceuticals, Inc. $0 Vir Biotechnology, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    4    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 44.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-12 8,000    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-04 3,333    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2007-06-06 73,575    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 16,838 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2008-02-20 90,369    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-11-03 0 2006-12-12 21,068    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 16,606 2007-11-27 83,975    Premium*  
            Glaukos Corp GKOS Director 2015-06-24 5,000 2015-06-24 0    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 2019-02-22 255,942 0    Premium*  
            Vir Biotechnology, Inc. VIR Director 2024-05-30 46,683 2024-05-30 495,890    Premium*  
            Allakos Inc. ALLK member - potential 10%... 2021-03-05 0 2021-03-05 2,071,147    Premium*  
            Tyra Biosciences, Inc. TYRA Director 0 2021-09-17 4,080,296    Premium*  
* Premium Members only  

Records found :    80         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-07-01 4 A $43.53 $72,739 D/D 1,671 47,700 0 -
TYRA Tyra Biosciences, Inc. Director   –       •      –    2021-09-17 4 A $0.00 $0 I/I 3,811,117 3,924,046 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2022-05-23 4 A $0.00 $0 D/D 6,405 42,435 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2022-06-09 4 A $0.00 $0 I/I 3,374 489,485 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2023-05-22 4 A $0.00 $0 D/D 6,027 45,088 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2023-10-19 4 A $0.00 $0 I/I 6,405 495,890 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2024-05-30 4 A $0.00 $0 D/D 8,000 46,683 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-05-20 4 AS $43.57 $519,351 D/D (11,670) 89,335 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-06-03 4 AS $44.56 $520,033 D/D (11,670) 81,039 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-06-17 4 AS $43.95 $512,840 D/D (11,670) 69,369 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-07-01 4 AS $44.31 $524,270 D/D (11,670) 57,699 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-07-15 4 AS $35.56 $415,012 D/D (11,670) 46,029 0 -
VIR Vir Biotechnology, Inc. Director   –       •      –    2021-07-29 4 AS $36.63 $429,723 D/D (11,670) 36,030 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-15 4 B $6.50 $2,999,997 I/I 461,538 98,075 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 B $12.00 $6,300,000 I/I 525,000 104,975 1.5 -
GKOS Glaukos Corp Director   –       •      –    2015-06-24 4 B $18.00 $90,000 D/D 5,000 5,000 2.39 -
SNNA Sienna Biopharmaceuticals...   –       •      –    2019-02-22 4 B $2.50 $250,000 D/D 100,000 255,942 0.01 -
TYRA Tyra Biosciences, Inc. Director   –       •      –    2021-09-17 4 B $16.00 $2,500,000 I/I 156,250 4,080,296 2.1 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2006-09-13 4 D $0.00 $0 I/I (571,000) 2,285,789 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-11-03 4 D $0.00 $0 I/I (634,000) 2,535,626 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-12-12 4 D $0.00 $0 I/I (581,176) 1,954,450 0 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2006-12-21 4 D $0.00 $0 I/I (571,000) 1,714,789 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2007-05-10 4 D $0.00 $0 I/I (864,406) 3,885,309 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2007-06-04 4 D $0.00 $0 I/I (1,000,000) 3,151,823 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-11-27 4 D $0.00 $0 I/I (900,000) 3,543,832 0 -
  80  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us